Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris

Protein Expression and Purification

Volumn 71, Issue 1, 2010, Pages 42-48

  Lee, Chang Han ^a   Choi, Dong Ki ^a   Choi, Hye Ji ^a   Song, Moo Young ^b   Kim, Yong Sung ^a  

^a Ajou University   (South Korea)

^b Yuhan Inc   (South Korea)

Author keywords

Fc engineering; Functional expression; Neonatal Fc receptor; Pichia pastoris; Two promoter vector system

Indexed keywords

ADALIMUMAB; FC RECEPTOR; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G; INFLIXIMAB; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; GENE VECTOR; GENETIC PROCEDURES; GENETIC TRANSFORMATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOUSE; PICHIA; PROMOTER REGION; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; SOLUBILITY;

ANIMALS; ANTIBODIES, MONOCLONAL; GENETIC TECHNIQUES; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; KINETICS; MICE; PICHIA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, FC; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; TRANSFORMATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA; PICHIA; PICHIA PASTORIS;

EID: 77049127990     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.12.004     Document Type: Article

References (22)

1. Roopenian D.C., and Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7 (2007) 715-725
2. Ghetie V., and Ward E.S. Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Annu. Rev. Immunol. 18 (2000) 739-766
3. Szlauer R., Ellinger I., Haider S., Saleh L., Busch B.L., Knofler M., and Fuchs R. Functional expression of the human neonatal Fc-receptor, hFcRn, in isolated cultured human syncytiotrophoblasts. Placenta 30 (2009) 507-515
4. Datta-Mannan A., Witcher D.R., Tang Y., Watkins J., Jiang W., and Wroblewski V.J. Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates. Drug Metab. Dispos. 35 (2007) 86-94
5. Raghavan M., Bonagura V.R., Morrison S.L., and Bjorkman P.J. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34 (1995) 14649-14657
6. Dall'Acqua W.F., Kiener P.A., and Wu H. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J. Biol. Chem. 281 (2006) 23514-23524
7. Datta-Mannan A., Witcher D.R., Tang Y., Watkins J., and Wroblewski V.J. Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J. Biol. Chem. 282 (2007) 1709-1717
8. Hinton P.R., Xiong J.M., Johlfs M.G., Tang M.T., Keller S., and Tsurushita N. An engineered human IgG1 antibody with longer serum half-life. J. Immunol. 176 (2006) 346-356
9. West Jr. A.P., and Bjorkman P.J. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor. Biochemistry 39 (2000) 9698-9708
10. Popov S., Hubbard J.G., Kim J., Ober B., Ghetie V., and Ward E.S. The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol. Immunol. 33 (1996) 521-530
11. Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., and Ward E.S. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int. Immunol. 13 (2001) 993-1002
12. Andersen J.T., Justesen S., Berntzen G., Michaelsen T.E., Lauvrak V., Fleckenstein B., Buus S., and Sandlie I. A strategy for bacterial production of a soluble functional human neonatal Fc receptor. J. Immunol. Methods 331 (2008) 39-49
13. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., Hengartner H., and Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187 (1998) 1383-1393
14. Kim M.S., Lee S.H., Song M.Y., Yoo T.H., Lee B.K., and Kim Y.S. Comparative analyses of complex formation and binding sites between human tumor necrosis factor-alpha and its three antagonists elucidate their different neutralizing mechanisms. J. Mol. Biol. 374 (2007) 1374-1388
15. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., and Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol. Ther. 117 (2008) 244-279
16. De Schutter K., Lin Y.C., Tiels P., Van Hecke A., Glinka S., Weber-Lehmann J., Rouze P., Van de Peer Y., and Callewaert N. Genome sequence of the recombinant protein production host Pichia pastoris. Nat. Biotechnol. 27 (2009) 561-566
17. Kim D.S., Lee S.H., Kim J.S., Lee S.C., Kwon M.H., and Kim Y.S. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting. Biochem. Biophys. Res. Commun. 379 (2009) 314-318
18. Sung E.S., Park K.J., Lee S.H., Jang Y.S., Park S.K., Park Y.H., Kwag W.J., Kwon M.H., and Kim Y.S. A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Mol. Cancer Ther. 8 (2009) 2276-2285
19. Graumann K., and Premstaller A. Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnol. J. 1 (2006) 164-186
20. Humphreys D.P., Carrington B., Bowering L.C., Ganesh R., Sehdev M., Smith B.J., King L.M., Reeks D.G., Lawson A., and Popplewell A.G. A plasmid system for optimization of Fab' production in Escherichia coli: importance of balance of heavy chain and light chain synthesis. Protein Expr. Purif. 26 (2002) 309-320
21. Kim K.J., Kim H.E., Lee K.H., Han W., Yi M.J., Jeong J., and Oh B.H. Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci. 13 (2004) 1698-1703
22. Kim J., Hayton W.L., Robinson J.M., and Anderson C.L. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin. Immunol. 122 (2007) 146-155